Answers are grounded in this paper and cite their sources.
Demonstrates equivalent performance of a novel assay for calprotectin and hemoglobin, suggesting improved clinical applications in ulcerative colitis.
The performance of the novel Fcal-LATIA was equivalent to that of the conventional Fcal assay. Simultaneous measurements with FITs would promote the clinical relevance of fecal biomarkers in UC.
No takes yet. Share an insight, caveat, or question.
Hiraoka et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: